Suven Life Sciences Ltd.

₹269.8

+ 0.10 (0.04%)

02:23 pm - close price

BSE: SUVEN

NSE: SUVEN

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -7.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -7.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -84.51Good: 20

❌

Current Ratio

Bad: 1Current: 3.21Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -84.88Good: 15

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -7.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -7.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -84.51Good: 20

❌

Current Ratio

Bad: 1Current: 3.21Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -84.88Good: 15

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	3.80	3.06	2.45	2.39	1.01
Expenditure+	31.81	26.57	48.64	32.67	31.54
Other Income+	5.64	5.14	6.07	4.28	4.01
Operating Profit	-28.01	-23.51	-46.19	-30.29	-30.54
Interest	0.05	0.04	0.03	0.03	0.02
Depreciation and Amortization	1.66	1.73	1.60	1.51	1.49
Profit Before Tax	-24.09	-12.68	-41.77	-27.54	-28.04
Tax+	0.00	0.00	0.00	-1.00	0.00
Net Profit	-24.09	-12.68	-41.77	-26.54	-28.04

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	1347.83	1184.43	1353.92	1169.30	665.58
Operational Expenses+	9341.90	13409.30	13930.11	13955.77	17230.95
Operating Profit	-7994.07	-12224.87	-12576.19	-12786.47	-16565.37
Other Income	775.37	160.13	844.90	2113.00	1089.69
OPM %	-593.11	-1032.13	-928.87	-1093.51	-2488.86
Depreciation and Amortisation	434.62	439.31	654.31	650.21	582.17
Interest	94.08	67.03	41.18	29.85	16.65
Profit Before Tax	-7747.40	-12199.51	-11826.78	-10607.87	-16074.50
Tax	-570.12	-	-	-	-
Net Profit	-7215.12	-12199.51	-11826.78	-10507.63	-16074.50

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	22231.50	20193.16	48280.77	28490.28	13518.33
Liabilities+	22231.50	20193.16	48280.77	28490.28	13518.33

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-9602.36	-12753.70	-11598.11	-11546.91	-15410.46
Cash from Investing Activity	5584.05	-2222.92	-24781.25	9443.63	15495.40
Cash from Financing Activity	3485.56	14569.16	39553.91	-105.40	-75.63
Net Cash Flow	-532.75	-407.46	3174.55	-2208.68	9.31
Opening Cash & Cash Equivalents	1467.57	934.82	527.36	3701.92	1493.24
Closing Cash & Cash Equivalents	934.82	527.36	3701.91	1493.24	1502.55

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	70.15	67.36	67.36	70.27	70.27	70.27	70.27	70.27	69.57	69.57
Public+	29.85	32.64	32.64	29.73	29.73	29.73	29.73	29.73	30.43	30.43
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	63915	64381	64921	66159	64603	63537	63975	66116	68959	74003

Corporate Actions

No corporate actions available for this company

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	1347.83	1184.43	1353.92	1169.30	665.58
Operational Expenses+	9341.90	13409.30	13930.11	13955.77	17230.95
Operating Profit	-7994.07	-12224.87	-12576.19	-12786.47	-16565.37
Other Income	775.37	160.13	844.90	2113.00	1089.69
OPM %	-593.11	-1032.13	-928.87	-1093.51	-2488.86
Depreciation and Amortisation	434.62	439.31	654.31	650.21	582.17
Interest	94.08	67.03	41.18	29.85	16.65
Profit Before Tax	-7747.40	-12199.51	-11826.78	-10607.87	-16074.50
Tax	-570.12	-	-	-	-
Net Profit	-7215.12	-12199.51	-11826.78	-10507.63	-16074.50

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	3.80	3.06	2.45	2.39	1.01
Expenditure+	31.81	26.57	48.64	32.67	31.54
Other Income+	5.64	5.14	6.07	4.28	4.01
Operating Profit	-28.01	-23.51	-46.19	-30.29	-30.54
Interest	0.05	0.04	0.03	0.03	0.02
Depreciation and Amortization	1.66	1.73	1.60	1.51	1.49
Profit Before Tax	-24.09	-12.68	-41.77	-27.54	-28.04
Tax+	0.00	0.00	0.00	-1.00	0.00
Net Profit	-24.09	-12.68	-41.77	-26.54	-28.04

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	-9602.36	-12753.70	-11598.11	-11546.91	-15410.46
Cash from Investing Activity	5584.05	-2222.92	-24781.25	9443.63	15495.40
Cash from Financing Activity	3485.56	14569.16	39553.91	-105.40	-75.63
Net Cash Flow	-532.75	-407.46	3174.55	-2208.68	9.31
Opening Cash & Cash Equivalents	1467.57	934.82	527.36	3701.92	1493.24
Closing Cash & Cash Equivalents	934.82	527.36	3701.91	1493.24	1502.55

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	22231.50	20193.16	48280.77	28490.28	13518.33
Liabilities+	22231.50	20193.16	48280.77	28490.28	13518.33

Shareholder Pattern

In %	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23
Promoters+	70.15	67.36	67.36	70.27	70.27	70.27	70.27	70.27	69.57	69.57
Public+	29.85	32.64	32.64	29.73	29.73	29.73	29.73	29.73	30.43	30.43
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	63915	64381	64921	66159	64603	63537	63975	66116	68959	74003

Corporate Actions

No corporate actions available for this company

Ratios

Reported EPS

Bad: 2Current: -7.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -7.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -84.51Good: 20

❌

Current Ratio

Bad: 1Current: 3.21Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -84.88Good: 15

❌

Debt to Total Assets

N/A

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -7.37Good: 5

❌

Adjusted EPS

Bad: 3Current: -7.37Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -84.51Good: 20

❌

Current Ratio

Bad: 1Current: 3.21Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: -84.88Good: 15

❌

Debt to Total Assets

N/A

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Suven Life Sciences Ltd.

₹269.8

+ 0.10 (0.04%)

02:23 pm - close price

BSE: SUVEN

NSE: SUVEN

Industry: Pharmaceuticals & Drugs

House: Private

Overview